Cartesian Therapeutics (RNAC)'s 30-day implied volatility (IV30) was 79.8% at the close on November 17, 2026, up from 69.7% the day before, against a 52-week range of 50.1% to 116.6%. Its 20-day historical volatility was 84.1%.
Data as of November 17, 2026.